2015
DOI: 10.1002/open.201402097
|View full text |Cite
|
Sign up to set email alerts
|

Site‐Specific Radioiodination of HER2‐Targeting Affibody Molecules using 4‐Iodophenethylmaleimide Decreases Renal Uptake of Radioactivity

Abstract: Affibody molecules are small scaffold-based affinity proteins with promising properties as probes for radionuclide-based molecular imaging. However, a high reabsorption of radiolabeled Affibody molecules in kidneys is an issue. We have shown that the use of 125I-3-iodo-((4-hydroxyphenyl)ethyl)maleimide (IHPEM) for site-specific labeling of cysteine-containing Affibody molecules provides high tumor uptake but low radioactivity retention in kidneys. We hypothesized that the use of 4-iodophenethylmaleimide (IPEM)… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 12 publications
(11 citation statements)
references
References 72 publications
(159 reference statements)
0
11
0
Order By: Relevance
“…Affibody molecules are non-immunoglobulin-based scaffold proteins characterized by high target specificity and binding affinity (Kd in the low-nanomolar to picomolar range) 52 , 53 . These small proteins have been generated against different cancer-associated molecular targets and have been labeled with different radionuclides ( 68 Ga, 18 F, 64 Cu, 99m Tc, and 111 In) suitable for immuno-PET and SPECT 54 - 59 .…”
Section: Resultsmentioning
confidence: 99%
“…Affibody molecules are non-immunoglobulin-based scaffold proteins characterized by high target specificity and binding affinity (Kd in the low-nanomolar to picomolar range) 52 , 53 . These small proteins have been generated against different cancer-associated molecular targets and have been labeled with different radionuclides ( 68 Ga, 18 F, 64 Cu, 99m Tc, and 111 In) suitable for immuno-PET and SPECT 54 - 59 .…”
Section: Resultsmentioning
confidence: 99%
“…[ 125 I]I-para-iodobenzoate is only one of the potential pendant groups providing a non-residualizing radioiodine label. Alternatively, labeled iodo-hydroxyphenylethyl-maleimide (I-HPEM) [55,56] or 4-iodophenethylmaleimide (I-PEM) [57] can be used for indirect radioiodination of affibody molecules. These alternative pendant groups have different rates of excretion from normal tissues compared to PIB, which opens an opportunity for finding the most suitable variant.…”
Section: Discussionmentioning
confidence: 99%
“…The release of activity from kidneys depends on the radioiodine-bearing prosthetic group and the position of its coupling to an affibody molecule. Therefore, the clearance of activity from kidneys is quicker when using 3-iodo-((4-hydroxyphenyl) ethyl)maleimide [55] and 3-bromo-((4-hydroxyphenyl)ethyl)maleimide [18] (Figure 2) than using 4-iodobenzoate and 4-bromobenzoate. The use of iodophenetylmaleimide ( Figure 2) as a precursor resulted in an even more rapid clearance of activity from kidneys [55].…”
Section: Biodistribution and Targeting Features Of Radiolabeled Affibmentioning
confidence: 99%
“…Therefore, the clearance of activity from kidneys is quicker when using 3-iodo-((4-hydroxyphenyl) ethyl)maleimide [55] and 3-bromo-((4-hydroxyphenyl)ethyl)maleimide [18] (Figure 2) than using 4-iodobenzoate and 4-bromobenzoate. The use of iodophenetylmaleimide ( Figure 2) as a precursor resulted in an even more rapid clearance of activity from kidneys [55]. Similarly, low renal uptake was associated with the use of non-residualizing radiofluorine labels N-2-(4-[ 18 [59] (Figure 3).…”
Section: Biodistribution and Targeting Features Of Radiolabeled Affibmentioning
confidence: 99%
See 1 more Smart Citation